Furthermore, the authors demonstrated that the JQ1 derivative (CPI203) inhibited T-ALL growth in mouse models of either FBXW7-mutated or wild type T-ALL, suggesting that FBXW7-mediated GSI resistance may be overcome by CPI203 treatment [139]. The gene discussed is FBXW7; the disease is acute lymphoblastic leukemia.